Cargando…

Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins

PURPOSE: There is no consensus on treatment volumes for adjuvant stereotactic body radiation therapy (SBRT) for pancreatic cancer. Herein, we report patterns of failure after pancreatic SBRT for close/positive margins, which may inform target volume design. METHODS AND MATERIALS: An institutional re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Ankur K., Rodríguez-López, Joshua L., Bahary, Nathan, Zureikat, Amer H., Burton, Steven A., Heron, Dwight E., Olson, Adam C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718532/ https://www.ncbi.nlm.nih.gov/pubmed/33305081 http://dx.doi.org/10.1016/j.adro.2020.08.006

Ejemplares similares

Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive Margins
por: Bernard, Mark E., et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
por: Sutera, Philip, et al.
Publicado: (2018)

One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective Review
por: Sutera, Philip Anthony, et al.
Publicado: (2017)

Evidence-Based Planning Target Volume Margin Reduction for Modern Lung Stereotactic Ablative Radiation Therapy Using Deformable Registration
por: Jasper, Katie, et al.
Publicado: (2021)

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer
por: Rajagopalan, Malolan S, et al.
Publicado: (2013)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma
por: Sutera, Philip A., et al.
Publicado: (2018)

Geometric Reproducibility of Fiducial Markers and Efficacy of a Patient-Specific Margin Design Using Deep Inspiration Breath Hold for Stereotactic Body Radiation Therapy for Pancreatic Cancer
por: Han-Oh, Sarah, et al.
Publicado: (2021)

Influence of intra- and interfraction motion on planning target volume margin in liver stereotactic body radiation therapy using breath hold
por: Oliver, Patricia A.K., et al.
Publicado: (2020)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy
por: Prasad, Rahul N., et al.
Publicado: (2021)

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)

Robotic Stereotactic Body Radiation Therapy for the Adjuvant Treatment of Early-Stage Breast Cancer: Outcomes of a Large Single-Institution Study
por: Jaysing, Anna, et al.
Publicado: (2022)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
por: Kim, Carolyn H, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease
por: Dohopolski, Michael J, et al.
Publicado: (2018)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
por: Lucido, J. John, et al.
Publicado: (2022)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
por: Schoenhals, Jonathan E., et al.
Publicado: (2021)

Transarterial Chemoembolization with LC Bead LUMI followed by Stereotactic Body Radiation Therapy in Treatment of Hepatocellular Carcinoma
por: Isaac, Evrosina I., et al.
Publicado: (2021)

A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy
por: Seyedin, Steven N., et al.
Publicado: (2021)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
por: Duriseti, Sai, et al.
Publicado: (2021)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
por: Fei, Naomi, et al.
Publicado: (2021)

Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, J.M., et al.
Publicado: (2022)

Assessment of biological dosimetric margin for stereotactic body radiation therapy
por: Kawahara, Daisuke, et al.
Publicado: (2020)

Efficacy and Safety of Stereotactic Body Radiation Therapy for Pediatric Malignancies: The LITE-SABR Systematic Review and Meta-Analysis
por: Singh, Raj, et al.
Publicado: (2023)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
por: Kishi, Noriko, et al.
Publicado: (2022)

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity
por: Jimenez, Rachel B., et al.
Publicado: (2017)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
por: Naccarato, Stefania, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity
por: Smith, Thomas, et al.
Publicado: (2020)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
por: Chan, Matthew, et al.
Publicado: (2020)

Improving Quality Metrics in Radiation Oncology: Implementation of Pretreatment Peer Review for Stereotactic Body Radiation Therapy in Patients with Thoracic Cancer
por: Kut, Carmen, et al.
Publicado: (2022)

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer
por: Jacobs, Bruce L., et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
por: Lee, Peter, et al.
Publicado: (2020)

Preoperative Stereotactic Body Radiation Therapy for Soft-Tissue Sarcoma: Results of Phase 2 Study
por: Kubicek, Gregory J., et al.
Publicado: (2021)

Phase I/II Study of Stereotactic Body Radiation Therapy for Pulmonary Metastases in Pediatric Patients
por: Liu, Kevin X., et al.
Publicado: (2020)

Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy
por: Rudra, Soumon, et al.
Publicado: (2020)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
por: Devpura, Suneetha, et al.
Publicado: (2021)

Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer
por: AlMasri, Samer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6h65kce73e44gqkl5p2i72p9uf